Abstract
Traditional toxicological tests generally provide descriptive information regarding the potential toxicity of chemicals, drugs and physical agents and are limited in their ability to assess risk to humans because they use model systems that are nonhuman in origin. Upon completion of the sequencing of the human genome, new tools were established that identify early biomarkers of toxicity and disease not only in model organisms but also in man. Gene expression profiling led to the development of a new subdiscipline of toxicology termed toxicogenomics. This new subdiscipline combines the emerging technologies of genomics, proteomics and bioinformatics to identify and characterize mechanisms of action of known and suspected toxicants. This chapter describes some advances in the area of toxicogenomics and discusses several models to study chemical-induced liver injury.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Casciano DA, Woodcock J. Empowering microarrays in the regulatory setting. Nature Biotechnol 2006; 24:1103.
Casciano DA, Fuscoe JC. Preface to mutation research special issue on toxicogenomics. Mut Res 2004; 549:1–3.
Hu T, Gibson DP, Carr GJ et al. Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins. Mut Res 2004;549:5–27.
Ackerman GS, Rozenzweig BA, Domon OE et al. Gene expression profiles and genetic damage in benzo[a] pyrene diol epoxide-exposed TK6 cells. Mut Res 2004;549:43–64.
Desai VG, Moland CL, Branham WS et al. Changes in gene expression as a function of time of day in the liver of rats. Mut Res 2004;549:115–129.
Boorman GA, Blackshear PE, Parker JS et al. Hepatic gene expression changes throughout the day in the Fischer rat: Implications for toxicogenomic experiments. Toxicol Sci 2005;86:185–193.
Desai VG, Fuscoe JC. Transcriptional profiling for understanding the basis of mitochondrial involvement in disease and toxicity using the mitochondria-specific MitoChip. Mut Res 2007;616:210–212.
Desai VG, Lee T, Delongchamp RR et al. Nucleoside reverse transcriptase (NRTIs)-induced expression profile of mitochondria related genes in the mouse liver. Mitochondrion 2008;8:181–195.
Poirier MC, Div RL, Al-Hari L et al. Long-term mitochondrial toxicity in HIV-infected infants born to HIV-infected mothers. J Acquired Immune Def Syndromes 2003;33:175–183.
Cornwell PD, DeSouza AT, Ulrich RG. Profiling of hepatic gene expression in rats treated with fibric acid analogs. Mut Res 2004;549:131–145.
Huang Q, Jin X, Gaillard ET et al. Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants. Mut Res 2004;549:147–168.
Guillouzo A. Liver models in in vitro toxicology. Env Health Persp 1998;106:511–532.
Casciano DA. Development and utilization of primary hepatocyte culture systems to evaluate metabolism, DNA binding and repair of xenobiotics. Drug Metab Rev 2000;32:1–14.
Casciano DA. The potent hepatocarcinogens methapyrilene: A hypothesis regarding its hepatotoxicity. In: Sahu S, ed. Hepatotoxicity: From Genomics to In Vitro and In Vivo Models. Chichester: J Wiley and Sons, 2007:578–587.
Harris AJ, Shaddock JG, Manjanatha MG et al. Identification of differentially expressed genes in aflatoxin B1-treated cultured primary rat hepatocytes and Fischer 344 rats. Carcinogenesis 1998;19:101–109.
Harris AJ, Dial SL, Casciano DA. Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells. Mut Res 2004;549:79–99.
Harris AJ, Casciano DA. Use of DNA arrays in understanding hepatic test systems. In Sahu S, ed. Hepatotoxicity: From genomics to in vitro and in vivo models, Chichester: J Wiley and Sons Ltd, 2007:489–506.
Bonney RJ, Walker PR, Potter VR. Isozyme patterns in parenchymal and nonparenchymal cells isolated from regenerating and regenerated liver. Biochem J 1974;32:947–954.
Bonney RJ, Becker JE, Walker PR et al. Adult liver parenchymal cells in primary culture characteristics and standards. In Vitro 1974;10:130–142.
Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biology 1976;13:29–83.
McMillan JM, Shaddock JG, Casciano DA et al. Effects of dexamethasone on drug metabolizing enzyme activities in primary rat hepatocyte cultures. Mut Res 2001;249:81–92.
LeCluse E. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci 2001;13:343–368.
Davila JC, Rodrigues RJ, Melchert RB et al. Predictive value of in vitro model systems in toxicology. Ann Rev Pharmacol Toxicol 1998;38:63–96.
Davila JC, Morris DL. Analysis of cytochrome P450 and phase II conjugating enzyme expression in adult male rat hepatocytes. In Vitro Cell Dev Biol 1999;35:120–130.
Yanagimoto T, Susmu I, Sawada M et al. Molecular cloning and functional expression of a mouse cytochrome P-450 (Cyp3a-13): examination of Cyp3a-13 enzyme to activate aflatoxin B1 (AFB1). Biochem Biophys Acta 1994;1201:405–410.
Aoyama T, Yamano S, Guzelian PS et al. Five of 12 forms of vaccine virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. Proc Natl Acad Sci USA 1990;87:4790–4793.
Shimada T, Guengerich FP. Evidence for cytochrome P-450NF, the nifedine oxidase, being the principal enzyme involved in the bioactivation of aflatoxin in human liver. Proc Natl Acad Sci USA 1989;86:462–465.
Metcalfe SA, Colley PJ, Neal GE. A comparison of the effects of pretreatment with Phenobarbital and 3-methylcholanthrene on the metabolism of aflatoxin B1 by liver rat microsomes and isolated hepatocytes in vitro. Chem Biol Interact 1981;35:145–157.
Chen L, Hardwick JP. Identification of a new P450 subfamily, CYP4F1, expressed in rat hepatic tumors. Arch Biochem Biophys 1993;300:18–23.
Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma protein and hepatitis B surface antigen. Science 1980;209:497–499.
Wang K, Shindoh H, Inoue T et al. Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines. J Toxicol Sci 2002;27;229–237.
Harris AJ. Modulation of gene expression in chemical carcinogenesis: Analysis of aflatoxin B1induced gene expression in primary human hepatocytes. Thesis. Little Rock: The University of Arkansas for Medical Sciences, 2001.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Casciano, D.A. (2012). The Use of Genomics in Model in Vitro Systems. In: Balls, M., Combes, R.D., Bhogal, N. (eds) New Technologies for Toxicity Testing. Advances in Experimental Medicine and Biology, vol 745. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3055-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3055-1_12
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3054-4
Online ISBN: 978-1-4614-3055-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)